Endometriosis
Conditions
Interventions
Test Group:Jiawei Mojie Tablet
Placebo Group:placebo
Sponsors
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Meet the diagnostic criteria of endometriosis-related dysmenorrhea. 2.Meet the syndrome differentiation requirements of qi stagnation and blood stasis syndrome. 3.The maximum VAS score for dysmenorrhea within the last 3 menstrual cycles =4. 4.Patients who have regular menstrual cycles (21-35 days) with periods for 3-7 days. 5.Age =20 years and =40 years. 6.Understand, agree to participate in this study and sign the informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients who suffer from primary dysmenorrhea, ovarian malignant carcinoma, adenomyosis and chronic pelvic inflammatory disease and so on. 2.Patients who have used medicine or other therapies (including laparoscopy) for endometriosis or traditional Chinese medicine and Chinese patent medicine with the efficacy of regulating qi and removing blood stasis within the last 3 months. 3.The diameter of ovarian endometrioma = 5cm. 4.SCr > the upper limit of normal, ALT or AST = 1.5 times the upper limit of normal, or hemoglobin = 90g/L. 5.Patients who have used long-acting contraceptive injections or implants within the last 6 months. Patients who have used contraceptives or medicated intrauterine devices within the last 8 weeks. And patients who are going to prepare for pregnancy within half a year as well as patients who are in pregnancy or in lactation. 6.Patients who complicate with heart, liver, kidney or other serious primary diseases, and patients who are psychopaths. 7.Patients who are suspected or confirmed to have the history of alcoholic abuse or drug abuse. 8.Patients who are suspected or confirmed to be allergic to ingredients or auxiliary materials of experimental drugs and emergency drugs. 9.Patients who have participated in or are currently participating in other clinical trials within the last 3 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The mean VAS score for dysmenorrhea after 3 treatments; | — |
Secondary
| Measure | Time frame |
|---|---|
| The maximum VAS score for dysmenorrhea;The hours of VAS score=4 during a menstrual cycle;The CMSS score of dysmenorrhea syndromes severity;The CMSS score of dysmenorrhea syndromes duration;TCM syndrome score;Menstruation characteristics score;Tumor markers (CA125 and CA199);Uterine and adnexal ultrasound;The Endometriosis Health Profile-5; | — |
Countries
China
Contacts
Public ContactDong Li
Yueyang integrated traditional Chinese and Western Medicine Hospital Affiliated to Shanghai University of traditional Chinese Medicine
Outcome results
None listed